| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |